Polyurethanes from modified castor oil and chitosan
Source abstract
Abstract
Polyurethanes (PUs) from castor oil (CO), modified CO (MCO) by transesterification reaction, isophorone diisocyanate (IPDI) in an NCO/OH ratio equal to 1, and chitosan (CS) were synthesized to assess their potential as biomaterials. PUs were characterized by Fourier transform infrared spectroscopy, hydroxyl value (ASTM D1957), thermogravimetric analysis, Shore A hardness (ASTM D2240), and scanning electronic microscopy (SEM). Also, contact angle, water retention and in vitro degradation in PBS, and cell viability on fibroblast were performed. The hydroxyl value confirms CO modification, and IR analysis confirms urethane bond formation. The thermal assay does not show new degradation stages and polyol with a high functionality had better hardness performance due to the increase in cross-linking. The micrograph shows micro-phase separation of both polymers. The contact angle shows the hydrophobic surface with an angle over 65°, and the CS and polyol type do not affect swelling and in vitro degradation due to phase separation between both polymers. The cell viability was over 70% in all cases, and solid polymers and degradation products involve non-cytotoxic effects on the samples. The results suggest a potential for these formulations in the biomedical field.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer composites and self-healing · Nanocomposite Films for Food Packaging · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Energy, Materials and Environmental Group, GEMA, Universidad de La Sabana, Chia, Cundinamarca, Colombia
Doctoral program of Biosciense, Universidad de La Sabana, Chia, Cundinamarca, Colombia
Bioprospecting Research Group, GIBP, Universidad de La Sabana, Chia, Cundinamarca, Colombia
Center for Biomaterials and Tissue Engineering, CBIT, Universitat Politècnica de València, Valencia, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain
References (30)
Show source-provided references
1. 10.1016/j.msec.2014.05.03010.1016/j.msec.2014.05.030 ↗
2. Szycher M.
3. 10.1515/revce-2015-003510.1515/revce-2015-0035 ↗
4. 10.1177/088391151456066110.1177/0883911514560661 ↗
5. Valero MF · Rev Latinoam Metal y Mater · 2016 · 36 · 9
6. 10.1016/j.actbio.2013.08.04010.1016/j.actbio.2013.08.040 ↗
7. 10.1177/009524431243715510.1177/0095244312437155 ↗
8. 10.1016/j.ijbiomac.2006.06.02310.1016/j.ijbiomac.2006.06.023 ↗
9. 10.1016/j.ijsu.2014.03.00510.1016/j.ijsu.2014.03.005 ↗
10. 10.1177/009524431351498910.1177/0095244313514989 ↗
11. 10.1016/j.polymdegradstab.2011.07.00210.1016/j.polymdegradstab.2011.07.002 ↗
12. 10.1016/j.eurpolymj.2012.12.00910.1016/j.eurpolymj.2012.12.009 ↗
13. 10.1016/j.biotechadv.2007.07.00910.1016/j.biotechadv.2007.07.009 ↗
14. 10.1016/j.progpolymsci.2011.02.00110.1016/j.progpolymsci.2011.02.001 ↗
15. 10.1016/j.colsurfb.2015.10.03910.1016/j.colsurfb.2015.10.039 ↗
16. 10.1016/j.biotechadv.2011.01.00510.1016/j.biotechadv.2011.01.005 ↗
17. 10.1016/j.actbio.2011.01.02910.1016/j.actbio.2011.01.029 ↗
18. 10.1016/j.ijbiomac.2012.08.00410.1016/j.ijbiomac.2012.08.004 ↗
19. 10.1016/j.biomaterials.2011.04.06110.1016/j.biomaterials.2011.04.061 ↗
20. 10.1016/j.biomaterials.2005.03.01610.1016/j.biomaterials.2005.03.016 ↗
21. 10.1590/S0104-1428200900010000810.1590/S0104-14282009000100008 ↗
22. Smalley RK · 165
23. 10.1016/j.polymdegradstab.2013.09.03210.1016/j.polymdegradstab.2013.09.032 ↗
24. 10.1016/j.carbpol.2010.04.06910.1016/j.carbpol.2010.04.069 ↗
25. 10.1016/j.indcrop.2014.05.01610.1016/j.indcrop.2014.05.016 ↗
26. 10.1590/S0100-4042200800080003110.1590/S0100-40422008000800031 ↗
27. Temenoff JS. · 2008
28. 10.1016/j.msec.2014.07.06110.1016/j.msec.2014.07.061 ↗
29. 10.1177/088532821666444810.1177/0885328216664448 ↗
30. 10.1080/09205063.2016.123994810.1080/09205063.2016.1239948 ↗